RoActemra (tocilizumab) - Important Safety Information from Roche as approved by the Irish Medicines Board

Notice type: 3rd Party Publications

Date: 13/12/2010

Problem Or Issue:
Important safety information communication from Roche on the association of tocilizumab (RoActemra^®) with anaphylaxis.

RoActemra (tocilizumab) - Important Safety Information

« Back